학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 436건 | 목록 10~20
Academic Journal
Steeghs N; The Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Gomez-Roca C; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Rohrberg KS; Rigshospitalet, Copenhagen, Denmark.; Mau-Sørensen M; Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Robbrecht D; Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quirón, Barcelona, Spain.; Ahmed S; University Hospitals of Leicester, Leicester, United Kingdom.; Rodriguez-Ruiz ME; University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Ardeshir C; Roche Products Ltd, United Kingdom.; Schmid D; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center, Germany.; Sleiman N; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.; Watson C; A4P Consulting Ltd, Sandwich, United Kingdom.; Piper-Lepoutre H; Pharmaceutical Sciences, Roche Innovation Center, Switzerland.; Dejardin D; Roche (Switzerland), Basel, Switzerland.; Evers S; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Boetsch C; Roche (Switzerland), Basel, Switzerland.; Charo J; Roche (Switzerland), Schlieren, Zurich, Switzerland.; Teichgräber V; Roche (Switzerland), Basel, Switzerland.; Melero I; Clinica Universidad de Navarra, CIBERONC, Pamplona, Navarra, Spain.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Report
SP II 2022-301, Discussion Papers / Wissenschaftszentrum Berlin für Sozialforschung, Forschungsschwerpunkt Markt und Entscheidung, Abteilung Ökonomik des Wandels, 83
Review
Totalitarismus und Demokratie, 4, 1, 186-189, Roberts, David D., 2006, The Totalitarian Experiment in Twentieth-Century Europe, New York, Routledge, 0-415-19278-1
Academic Journal
Robbrecht D; Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Grob JJ; Dermatology and Oncology Service, Aix Marseille University and Timone Hospital, Marseille, France.; Bechter O; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Simonelli M; Department of Biomedical Science, Humanitas University, Milan, Italy.; Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy.; Doger B; START Madrid-FJD, Early Phase Clinical Trials Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Borbath I; Department of Hepatogastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.; Butler MO; Department of Medical Oncology and Hematology, Department of Immunology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Cheng T; Division of Medical Oncology, Department of Oncology, University of Calgary, Calgary, Alberta, Canada.; Romano PM; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Pons-Tostivint E; Service d'oncologie médicale, CHU Nantes, Université de Nantes, Nantes, France.; Di Nicola M; Unit of Immunotherapy and Anticancer Innovative Therapeutics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Curigliano G; Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, CIBERONC, IMIM Research Institute, Barcelona, Spain.; Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany.; German Cancer Consortium, partner site Essen, Essen, Germany.; NCT-West, Campus Essen, Essen, Germany.; University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.; Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Abbadessa G; Sanofi, Bridgewater, New Jersey, USA.; Demers B; Sanofi, Vitry-Sur-Seine, France.; Amrate A; Sanofi, Vitry-Sur-Seine, France.; Wang H; Sanofi, Cambridge, Massachusetts, USA.; Lee JS; Sanofi, Cambridge, Massachusetts, USA.; Pomponio R; Sanofi, Cambridge, Massachusetts, USA.; Wang R; Sanofi, Cambridge, Massachusetts, USA.
Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Academic Journal
Rannikko JH; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland; Turku Doctoral Program of Molecular Medicine, University of Turku, Turku, Finland.; Verlingue L; Institut Gustave Roussy, Paris and Centre Leon Berard in Lyon, Lyon, France.; de Miguel M; START-CIOCC HM Sanchinarro, Madrid, Spain.; Pasanen A; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Robbrecht D; Erasmus Medical Center/Cancer Institute, Rotterdam, the Netherlands.; Skytta T; Tampere University Hospital, Tampere, Finland.; Iivanainen S; Oulu University Hospital, University of Oulu, Oulu, Finland.; Shetty S; University of Birmingham/University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Ma YT; University of Birmingham/University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Graham DM; The Christie NHS Foundation Trust, Manchester, UK.; Arora SP; Mays Cancer Center, UT Health San Antonio, San Antonio, TX, USA.; Jaakkola P; Department of Oncology, Turku University Hospital and University of Turku, Turku, Finland.; Yap C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.; Xiang Y; INDIVIDRUG Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Mandelin J; Faron Pharmaceuticals Ltd, Turku, Finland.; Karvonen MK; Faron Pharmaceuticals Ltd, Turku, Finland.; Jalkanen J; Faron Pharmaceuticals Ltd, Turku, Finland.; Karaman S; INDIVIDRUG Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Wihuri Research Institute, Helsinki, Finland.; Koivunen JP; Oulu University Hospital, University of Oulu, Oulu, Finland; Faron Pharmaceuticals Ltd, Turku, Finland.; Minchom A; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK.; Hollmén M; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland; Faron Pharmaceuticals Ltd, Turku, Finland. Electronic address: maijal@utu.fi.; Bono P; Terveystalo Finland and University of Helsinki, Helsinki, Finland. Electronic address: petri.bono@terveystalo.com.
Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Robbrecht, D.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어